| answer text |
<p>Public Health England (PHE) collects data on laboratory confirmed cases of invasive
meningococcal disease (IMD) in England. Data on case fatality rates is not available
in the format requested. National data on the number of cases of IMD in England are
published by PHE based on the number of laboratory confirmed cases. These data are
available at:</p><p>https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/470608/Table_1_Invasive_meningococcal_infections_lab_reports__England_by_capsular_group___epi_year.pdf</p><p>
</p><p>There are three meningococcal immunisation programmes in England at present
which offer MenB, MenC and MenACWY vaccines to different age groups. The MenB and
MenACWY vaccination programmes were both introduced within the last six months and
it is too early to confirm any impact on the incidence of the disease due to these
vaccines. The MenC vaccination programme has been in place since November 1999. In
1998/99, the epidemiological year before MenC vaccine was introduced, there were 883
cases of confirmed Group C IMD in England whereas in the last five epidemiological
years there have been an average 28 cases confirmed each year; a persisting reduction
of 97%.</p>
|
|
